April 3rd / The Faculty of Pharmacy at Jordan University of Science and Technology has received approval from the Council of Higher Education to begin offering a Master of Science in Pharmacoeconomics effective in the 2023-2024 academic year.

Prof. Khaled Al-Salem, President of the University, has confirmed that the program is in line with the university's strategy to keep current with contemporary disciplines and fields of science in the MENA region, and he has also asserted that the need for competencies and expertise in the field of Pharmacoeconomics in the labor market was the main impetus for the founding of this program.

This program is the first of its kind at the local Jordanian university level, and Prof. Al-Salem has stated that the approval to introduce this specialized knowledge by the Higher Education Council is certainly an affirmation of the university's status and interest in developing its programs and study plans in accordance with the latest developments and scientific knowledge.

​According to Prof. Sayer Al-Azzam, Dean of the College of Pharmacy, the goal of introducing Pharmacoeconomics is to familiarize students with the details of selecting the appropriate analysis method to measure and compare the economic, clinical, and humanistic outcomes of pharmaceutical care services. This program's study plan is distinctive in that it is based on integrated courses that provide qualified pharmacists with a head start on both theoretical and applied research. Moreover, electives aligned with global standards have been incorporated into the curriculum. Prof. Al-Azzam emphasized that the program will assist students grasp the fundamental principles and methods of research in Pharmacoeconomics, as well as the techniques of pharmacoeconomic modeling, decision analysis, and so on.

​